Amano S, Hazama F, Hamashima Y (1979) Pathology of Kawasaki disease: I. Pathology and morphogenesis of the vascular changes. Jpn Circ J 43:633–643

Article  CAS  PubMed  Google Scholar 

Takahashi K, Oharaseki T, Yokouchi Y (2011) Pathogenesis of Kawasaki disease. Clin Exp Immunol 164(Suppl 1):20–22

Article  PubMed  PubMed Central  Google Scholar 

Sundel RP (2002) Update on the treatment of Kawasaki disease in childhood. Curr Rheumatol Rep 4:474–482

Article  PubMed  Google Scholar 

Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1:845–867

Article  CAS  PubMed  Google Scholar 

Teshirogi T, Wakabayashi T (1985) Modified criteria for diagnosis of Kawasaki disease. Nihon Ika Daigaku Zasshi 52:342–346

Article  CAS  PubMed  Google Scholar 

Khurana M, Traum AZ, Aivado M, Wells MP, Guerrero M, Grall F, Libermann TA, Schachter AD (2006) Urine proteomic profiling of pediatric nephrotic syndrome. Pediatr Nephrol 21:1257–1265

Article  PubMed  PubMed Central  Google Scholar 

Issaq HJ, Veenstra TD, Conrads TP, Felschow D (2002) The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem Biophys Res Commun 292:587–592

Article  CAS  PubMed  Google Scholar 

Research Committee of the Japanese Society of Pediatric Cardiology, Cardiac Surgery Committee for Development of Guidelines for Medical Treatment of Acute Kawasaki Disease (2014) Guidelines for medical treatment of acute Kawasaki disease: Report of the Research Committee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (2012 revised version). Pediatr Int 56:135–158

Harada K (1991) Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 33:805–810

Article  CAS  PubMed  Google Scholar 

Shiraishi H, Iino M, Hoshina M, Ichihashi K, Momoi MY (2007) Intravenous immunoglobulin 1 g/kg as the initial treatment for Kawasaki disease. World J Pediatr 6:195–199

Google Scholar 

Kanai T, Shiraishi H, Uehara R, Ito T, Momoi MY (2012) Increased α1-antitrypsin levels in acute-phase Kawasaki disease as shown by SELDI-TOF MS analysis. Pediatr Cardiol 33:1343–1347

Article  PubMed  Google Scholar 

Shao S, Zhou K, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Wang C (2021) Predictive value of serum lipid for intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease. J Clin Endocrinol Metab 106:e4210–e4220

Article  PubMed  Google Scholar 

Lin J, Jain S, Sun X, Liu V, Sato YZ, Jimenez-Fernandez S, Newfield RS, Pourfarzib R, Tremoulet AH, Gordon JB, Daniels LB, Burns JC (2014) Lipoprotein particle concentrations in children and adults following Kawasaki disease. J Pediatr 165:727–731

Article  CAS  PubMed  PubMed Central  Google Scholar 

Newburger JW, Burns JC, Beiser AS, Loscalzo J (1991) Altered lipid profile after Kawasaki syndrome. Circulation 84:625–631

Article  CAS  PubMed  Google Scholar 

Baroni S, Scribano D, Valentini P, Zuppi C, Ranno O, Giardina B (1996) Serum apolipoprotein A1, B, CII, CIII, E, and lipoprotein (a) levels in children. Clin Biochem 29:603–605

Article  CAS  PubMed  Google Scholar 

Bornfeldt KE (2024) Apolipoprotein C3: form begets function. J Lipid Res 65:100475

Article  CAS  PubMed  Google Scholar 

Hsu CC, Shao B, Kanter JE, He Y, Vaisar T, Witztum JL, Snell-Bergeon J, McInnes G, Bruse S, Gottesman O, Mullick AE, Bornfeldt KE (2023) Apolipoprotein C3 induces inflammasome activation only in its delipidated form. Nat Immunol 24:408–411

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fredenrich A, Giroux LM, Tremblay M, Krimbou L, Davignon J, Cohn JS (1997) Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions. J Lipid Res 38:1421–1432

Article  CAS  PubMed  Google Scholar 

Kawakami A, Aikawa M, Alcaide P, Luscinskas FW, Libby P, Sacks FM (2006) Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells. Circulation 114:681–687

Article  CAS  PubMed  Google Scholar 

Jia C, Zhang J, Chen H, Zhuge Y, Chen H, Qian F, Zhou K, Niu C, Wang F, Qiu H, Wang Z, Xiao J, Rong X, Chu M (2019) Endothelial cell pyroptosis plays an important role in Kawasaki disease via HMGB1/RAGE/cathespin B signaling pathway and NLRP3 inflammasome activation. Cell Death Dis 10:778

Article  PubMed  PubMed Central  Google Scholar 

Fukazawa R, Ikegam E, Watanabe M, Hajikano M, Kamisago M, Katsube Y, Yamauchi H, Ochi M, Ogawa S (2007) Coronary artery aneurysm induced by Kawasaki disease in children show features typical senescence. Circ J 71:709–715

Article  PubMed  Google Scholar 

Schiller B, Elinder G (1999) Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment. Acta Paediatr 88:844–848

Article  CAS  PubMed  Google Scholar 

Takahashi K, Oharaseki T, Yokouchi Y (2018) Histopathological aspects of cardiovascular lesions in Kawasaki disease. Int J Rheum Dis 21:31–35

Article  CAS  PubMed  Google Scholar 

Zewinger S, Reiser J, Jankowski V, Alansary D, Hahm E, Triem S, Klug M, Schunk SJ, Schmit D, Kramann R, Körbel C, Ampofo E, Laschke MW, Selejan SR, Paschen A, Herter T, Schuster S, Silbernagel G, Sester M, Sester U, Aßmann G, Bals R, Kostner G, Jahnen-Dechent W, Menger MD, Rohrer L, März W, Böhm M, Jankowski J, Kopf M, Latz E, Niemeyer BA, Fliser D, Laufs U, Speer T (2020) Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation. Nat Immunol 21:30–41

Article  CAS  PubMed  Google Scholar 

Zhang H, Song HB, Wang DX, Deng HY, Sun WL (2022) Correlation between the level of inflammatory cytokines and prognosis in children with IVIG-sensitive Kawasaki disease and IVIG-resistant Kawasaki disease. Pak J Med Sci 38:1165–1169

Article  PubMed  PubMed Central  Google Scholar 

Olivieri O, Gasperini S, Calzetti F, Gardiman E, Castagna A, Martinelli N, Tamassia N, Cassatella MA (2023) CD14(+)-monocytes exposed to apolipoprotein CIII express tissue factor. Int J Mol Sci 24(3):2223

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E (2017) Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927–e999

Article  PubMed  Google Scholar